BTIG analyst Ryan Zimmerman maintained a Buy rating on Tactile Systems Technology (TCMD) yesterday and set a price target of $51.00. The company’s shares closed last Monday at $37.17.
According to TipRanks.com, Zimmerman is a 4-star analyst with an average return of 9.7% and a 49.6% success rate. Zimmerman covers the Healthcare sector, focusing on stocks such as Zimmer Biomet Holdings, Staar Surgical Company, and Integra Lifesciences.
Currently, the analyst consensus on Tactile Systems Technology is a Strong Buy with an average price target of $61.00.
See today’s analyst top recommended stocks >>
Based on Tactile Systems Technology’s latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of $35.12 million and GAAP net loss of $13.85 million. In comparison, last year the company earned revenue of $45.2 million and had a net profit of $2.79 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Tactile Systems Technology, Inc. is a medical technology company. It develops and provides innovative medical devices for the treatment of chronic diseases at home. The company focus on advancing the standard of care in treating chronic diseases in the home setting to improve patient outcomes and quality of life and help control rising healthcare expenditures. It possesses a platform to deliver at-home healthcare solutions throughout the United States. Tactile Systems Technology was founded on January 30, 1995 and is headquartered in Minneapolis, MN.
